[1]
|
Sung, H., et al. (2021) Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA: A Cancer Journal for Clinicians, 71, 209-249. https://doi.org/10.3322/caac.21660
|
[2]
|
Martinez Rodriguez, R.H., Buisan Rueda, O. and Ibarz, L. (2017) Bladder Cancer: Present and Future. Medicina Clínica (Barc), 149, 449-455. https://doi.org/10.1016/j.medcle.2017.10.005
|
[3]
|
Hurst, C.D., et al. (2017) Genomic Subtypes of Non-Invasive Bladder Cancer with Distinct Metabolic Profile and Female Gender Bias in KDM6A Mutation Frequency. Cancer Cell, 32, 701-715.e7.
https://doi.org/10.1016/j.ccell.2017.08.005
|
[4]
|
Smolensky, D., Rathore, K. and Cekanova, M. (2016) Molecular Targets in Urothelial Cancer: Detection, Treatment, and Animal Models of Bladder Cancer. Drug Design, Develop-ment and Therapy, 10, 3305-3322.
https://doi.org/10.2147/DDDT.S112113
|
[5]
|
Kojima, T., et al. (2017) Biomarkers for Precision Medicine in Bladder Cancer. International Journal of Clinical Oncology, 22, 207-213. https://doi.org/10.1007/s10147-016-1068-8
|
[6]
|
Lin, T.Y., et al. (2016) Novel Theranostic Nanoporphyrins for Photodynamic Diagnosis and Trimodal Therapy for Bladder Cancer. Biomaterials, 104, 339-351. https://doi.org/10.1016/j.biomaterials.2016.07.026
|
[7]
|
Zhou, J., et al. (2022) An Oncogenic JMJD6-DGAT1 Axis Tunes the Epigenetic Regulation of Lipid Droplet Formation in Clear Cell Renal Cell Carcinoma. Molecular Cell, 82, 3030-3044.E8. https://doi.org/10.1016/j.molcel.2022.06.003
|
[8]
|
Wright, M.D., Ni, J. and Rudy, G.B. (2000) The L6 Membrane Proteins—A New Four-Transmembrane Superfamily. Protein Science, 9, 1594-1600. https://doi.org/10.1110/ps.9.8.1594
|
[9]
|
Tang, Q., et al. (2020) TM4SF1 Promotes EMT and Cancer Stemness via the Wnt/beta-Catenin/SOX2 Pathway in Colorectal Cancer. Journal of Experimental & Clinical Cancer Research, 39, Article No. 232.
https://doi.org/10.1186/s13046-020-01690-z
|
[10]
|
Rahim, N.S., et al. (2023) Three Members of Transmembrane-4-Superfamily, TM4SF1, TM4SF4, and TM4SF5, as Emerging Anticancer Molecular Targets against Cancer Phenotypes and Chemoresistance. Pharmaceuticals (Basel), 16, Article 110. https://doi.org/10.3390/ph16010110
|
[11]
|
Jung, J.W., et al. (2020) Amino Acid Transporters as Tetraspanin TM4SF5 Binding Partners. Experimental & Molecular Medicine, 52, 7-14. https://doi.org/10.1038/s12276-019-0363-7
|
[12]
|
Hou, S., et al. (2022) TM4SF1 Promotes Esophageal Squamous Cell Carcinoma Metastasis by Interacting with Integrin α6. Cell Death & Disease, 13, Article No. 609. https://doi.org/10.1038/s41419-022-05067-2
|
[13]
|
Huang, Y.K., Fan, X.G. and Qiu, F. (2016) TM4SF1 Promotes Proliferation, Invasion, and Metastasis in Human Liver Cancer Cells. International Journal of Molecular Sciences, 17, Article 661. https://doi.org/10.3390/ijms17050661
|
[14]
|
Gao, C., et al. (2019) TM4SF1 Is a Potential Target for Anti-Invasion and Metastasis in Ovarian Cancer. BMC Cancer, 19, Article No. 237. https://doi.org/10.1186/s12885-019-5417-7
|
[15]
|
Jung, K., et al. (2021) TM4SF4 and LRRK2 Are Potential Therapeutic Targets in Lung and Breast Cancers through Outlier Analysis. Cancer Research and Treatment, 53, 9-24. https://doi.org/10.4143/crt.2020.434
|
[16]
|
Zhang, F., et al. (2022) TYMS-TM4SF4 Axis Promotes the Progression of Colorectal Cancer by EMT and Upregulating Stem Cell Marker. American Journal of Cancer Research, 12, 1009-1026.
|
[17]
|
Jung, O., et al. (2012) Tetraspan TM4SF5-Dependent Direct Activation of FAK and Metastatic Po-tential of Hepatocarcinoma Cells. Journal of Cell Science, 125, 5960-5973. https://doi.org/10.1242/jcs.100586
|
[18]
|
Lee, S.A., et al. (2008) Tetraspanin TM4SF5 Mediates Loss of Contact Inhibition through Epithelial-Mesenchymal Transition in Human Hepatocarcinoma. Journal of Clinical Investigation, 118, 1354-1366.
https://doi.org/10.1172/JCI33768
|
[19]
|
Qin, X., et al. (2022) Immune-Related Gene TM4SF18 Could Promote the Metastasis of Gastric Cancer Cells and Predict the Prognosis of Gastric Cancer Patients. Molecular Oncology, 16, 4043-4059.
https://doi.org/10.1002/1878-0261.13321
|
[20]
|
Singhal, M., et al. (2019) TM4SF18 Is Aberrantly Expressed in Pancreatic Cancer and Regulates Cell Growth. PLOS ONE, 14, e0211711. https://doi.org/10.1371/journal.pone.0211711
|
[21]
|
Luo, M., et al. (2022) TM4SF19-AS1 Facilitates the Prolifer-ation of Lung Squamous Cell Carcinoma by Recruiting WDR5 to Mediate TM4SF19. Molecular and Cellular Probes, 65, Article 101849.
https://doi.org/10.1016/j.mcp.2022.101849
|
[22]
|
张蕊. 基于生物信息学分析TM4SF19在肺鳞状细胞癌中的表达及意义[D]: [硕士学位论文]. 沈阳: 中国医科大学, 2023.
|
[23]
|
俞思薇, 王红霞. 四次跨膜蛋白超家族成员与肿瘤的研究进展[J]. 中国细胞生物学学报, 2022, 44(4): 672-681.
|
[24]
|
王坤. TM4SF1在甲状腺乳头状癌淋巴结转移中的作用及机制研究[D]: [博士学位论文]. 济南: 山东大学, 2023.
|
[25]
|
李昆, 等. 乳腺癌患者血清CEACAM1、TM4SF1水平变化及其临床意义[J]. 山东医药, 2022, 62(16): 14-18.
|
[26]
|
李昌安, 等. TM4SF1水平与胃癌病理特征的相关性[J]. 实用癌症杂志, 2021, 36(10): 1614-1616+1643.
|
[27]
|
霍宏志, 梁金, 柴尔青. TM4SF1与脑胶质瘤病理分级及预后的相关性[J]. 中国临床神经外科杂志, 2022, 27(6): 447-451.
|
[28]
|
胡效林, 等. SLC1A5协同TM4SF1通过mTOR信号通路调控食管鳞癌细胞迁移[J]. 实用临床医药杂志, 2023, 27(14): 33-39+45.
|
[29]
|
盖欣欣, 等. TM4SF1对结直肠癌细胞增殖、迁移及凋亡的影响[J]. 牡丹江医学院学报, 2023, 44(3): 1-4+13.
|
[30]
|
Vivian, J., et al. (2017) Toil Enables Reproducible, Open Source, Big Biomedical Data Analyses. Nature Biotechnology, 35, 314-316. https://doi.org/10.1038/nbt.3772
|
[31]
|
Ritchie, M.E., et al. (2015) limma Powers Differential Expression Analyses for RNA-Sequencing and Microarray Studies. Nucleic Acids Research, 43, e47. https://doi.org/10.1093/nar/gkv007
|
[32]
|
Love, M.I., Huber, W. and Anders, S. (2014) Moderated Estimation of Fold Change and Dispersion for RNA-Seq Data with DESeq2. Genome Biology, 15, Article No. 550. https://doi.org/10.1186/s13059-014-0550-8
|
[33]
|
Yu, G., et al. (2012) clusterProfiler: An R Package for Com-paring Biological Themes among Gene Clusters. OMICS, 16, 284-287. https://doi.org/10.1089/omi.2011.0118
|
[34]
|
Subramanian, A., et al. (2005) Gene Set Enrichment Analysis: A Knowledge-Based Approach for Interpreting Genome-Wide Expression Profiles. Proceedings of the National Academy of Sciences of the United States of America, 102, 15545-15550. https://doi.org/10.1073/pnas.0506580102
|
[35]
|
Hänzelmann, S., Castelo, R. and Guinney, J. (2013) GSVA: Gene Set Variation Analysis for Microarray and RNA-Seq Data. BMC Bioinformatics, 14, Article No. 7. https://doi.org/10.1186/1471-2105-14-7
|
[36]
|
Bindea, G., et al. (2013) Spatiotemporal Dynamics of Intratumoral Immune Cells Reveal the Immune Landscape in Human Cancer. Immunity, 39, 782-795. https://doi.org/10.1016/j.immuni.2013.10.003
|
[37]
|
Gu, Z., et al. (2014) circlize Implements and Enhances Cir-cular Visualization in R. Bioinformatics, 30, 2811-2812.
https://doi.org/10.1093/bioinformatics/btu393
|
[38]
|
Liu, J., et al. (2018) An Integrated TCGA Pan-Cancer Clin-ical Data Resource to Drive High-Quality Survival Outcome Analytics. Cell, 173, 400-416.e11. https://doi.org/10.1016/j.cell.2018.02.052
|
[39]
|
Takan, I., et al. (2023) “In the Light of Evolution”: Keratins as Exceptional Tumor Biomarkers. PeerJ, 11, e15099.
https://doi.org/10.7717/peerj.15099
|
[40]
|
Karsch, S., et al. (2020) An Intact Keratin Network Is Crucial for Me-chanical Integrity and Barrier Function in Keratinocyte Cell Sheets. Cellular and Molecular Life Sciences, 77, 4397-4411. https://doi.org/10.1007/s00018-019-03424-7
|
[41]
|
Zhang, N., et al. (2017) Keratin 23 Promotes Te-lomerase Reverse Transcriptase Expression and Human Colorectal Cancer Growth. Cell Death & Disease, 8, e2961. https://doi.org/10.1038/cddis.2017.339
|
[42]
|
Bilandzic, M., et al. (2019) Keratin-14 (KRT14) Positive Leader Cells Mediate Mesothelial Clearance and Invasion by Ovarian Cancer Cells. Cancers (Basel), 11, Article 1228. https://doi.org/10.3390/cancers11091228
|
[43]
|
Zhao, H., et al. (2021) Inflammation and Tumor Progression: Signaling Pathways and Targeted Intervention. Signal Transduction and Targeted Therapy, 6, Article No. 263. https://doi.org/10.1038/s41392-021-00658-5
|
[44]
|
Paluch, E.K., Aspalter, I.M. and Sixt, M. (2016) Focal Adhe-sion-Independent Cell Migration. Annual Review of Cell and Developmental Biology, 32, 469-490. https://doi.org/10.1146/annurev-cellbio-111315-125341
|
[45]
|
Eke, I. and Cordes, N. (2015) Focal Adhesion Sig-naling and Therapy Resistance in Cancer. Seminars in Cancer Biology, 31, 65-75. https://doi.org/10.1016/j.semcancer.2014.07.009
|
[46]
|
Banyard, J. and Bielenberg, D.R. (2015) The Role of EMT and MET in Cancer Dissemination. Connective Tissue Research, 56, 403-413. https://doi.org/10.3109/03008207.2015.1060970
|
[47]
|
Castaño, Z., et al. (2018) IL-1β Inflammatory Response Driven by Primary Breast Cancer Prevents Metastasis-Initiating Cell Colonization. Nature Cell Biology, 20, 1084-1097. https://doi.org/10.1038/s41556-018-0173-5
|
[48]
|
范彦鹏. 基于单细胞RNA测序分析膀胱癌组织肿瘤微环境的转录异质性[D]: [硕士学位论文]. 长春: 吉林大学, 2023.
|
[49]
|
叶峻江, 等. 肿瘤相关成纤维细胞在膀胱癌发生发展中的研究进展[J]. 临床泌尿外科杂志, 2023, 38(10): 796-802.
|
[50]
|
张建军, 等. 膀胱肿瘤微环境细胞亚群分布及与复发的关系[J]. 临床医药实践, 2023, 32(8): 570-573.
|
[51]
|
张庆磊, 等. 肿瘤微环境中CD4+T细胞浸润、MFAP5与膀胱癌患者预后关系的临床研究[J]. 中国免疫学杂志, 2023, 39(8): 1719-1723.
|
[52]
|
Schreiber, R.D., Old, L.J. and Smyth, M.J. (2011) Cancer Immunoediting: Integrating Immunity’s Roles in Cancer Suppression and Promotion. Science, 331, 1565-1570. https://doi.org/10.1126/science.1203486
|
[53]
|
Cassetta, L. and Pollard, J.W. (2018) Targeting Macrophages: Therapeutic Approaches in Cancer. Nature Reviews Drug Discovery, 17, 887-904. https://doi.org/10.1038/nrd.2018.169
|
[54]
|
DeNardo, D.G. and Ruffell, B. (2019) Macrophages as Regulators of Tumour Immunity and Immunotherapy. Nature Reviews Immunology, 19, 369-382. https://doi.org/10.1038/s41577-019-0127-6
|
[55]
|
Lorvik, K.B., et al. (2016) Adoptive Transfer of Tumor-Specific Th2 Cells Eradicates Tumors by Triggering an in Situ Inflammatory Immune Response. Cancer Research, 76, 6864-6876. https://doi.org/10.1158/0008-5472.CAN-16-1219
|
[56]
|
Dai, M., et al. (2018) Tumor Regression and Cure Depends on Sustained Th1 Responses. Journal of Immunotherapy, 41, 369-378. https://doi.org/10.1097/CJI.0000000000000231
|
[57]
|
DeNardo, D.G., et al. (2009) CD4(+) T Cells Regulate Pul-monary Metastasis of Mammary Carcinomas by Enhancing Protumor Properties of Macrophages. Cancer Cell, 16, 91-102. https://doi.org/10.1016/j.ccr.2009.06.018
|
[58]
|
Espinoza, J.A., et al. (2016) Cytokine Profiling of Tumor Interstitial Fluid of the Breast and Its Relationship with Lymphocyte Infiltration and Clinicopathological Character-istics. Oncoimmunology, 5, e1248015.
https://doi.org/10.1080/2162402X.2016.1248015
|
[59]
|
Feng, Q., et al. (2012) Th2 Type Inflammation Promotes the Gradual Progression of HPV-Infected Cervical Cells to Cervical Carcinoma. Gynecologic Oncology, 127, 412-419.
|